Monthly Archives:

Telling Causes of The Ozempic® / Wegovy® Shortages

If you haven’t heard, there is a significant shortage of a diabetes drug marketed as Ozempic® along with another semaglutide formulation, known as Wegovy®, FDA-approved for obesity. Semaglutides are a very effective therapy for those with sugar control issues as they stimulate insulin production in the body. However, this class […]